Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New app aims to break stigma for pregnant teens with HIV

NCT ID NCT05383755

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study developed and tested a digital intervention for pregnant unmarried adolescents aged 15-19 living with HIV in Kenya. The app uses stories and lessons to help them understand stigma, build confidence to disclose their HIV and pregnancy status to family, and seek support. 169 participants used the app and provided feedback on its usability and impact. The goal is to improve their mental health and engagement in services that prevent passing HIV to their babies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital intervention (mobile app with illustrative characters and didactic content)
What this could lead to
If successful, this could lead to a scalable digital tool that helps pregnant teens with HIV manage stigma, improve communication with family, and increase engagement in prevention of mother-to-child transmission services.
What could go wrong
This is a small, early-stage pilot (169 participants) focused on feasibility and acceptability, not on clinical outcomes. The intervention may not work in larger, more diverse populations or in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

169 people

The number who actually took part.

Started

Mar 2022

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 19 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for adolescent participants: * Female * Living with HIV * Pregnant * Unmarried * 15-19 years old Exclusion criteria for all participants: * Does not meet all inclusion criteria * Participated in a prior study activity * Does not show adequate understanding of consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Kenya Medical Research Institute - Centre for Global Health Research

    Kisumu, 40100, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.